- Home
- TLSI vs GHG Comparison
TLSI vs GHG Comparison
Compare TLSI & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- GHG
- Stock Information
- Founded
- TLSI 2010
- GHG 2004
- Country
- TLSI United States
- GHG China
- Employees
- TLSI N/A
- GHG N/A
- Industry
- TLSI Medical Specialities
- GHG Hotels/Resorts
- Sector
- TLSI Health Care
- GHG Consumer Discretionary
- Exchange
- TLSI Nasdaq
- GHG Nasdaq
- Market Cap
- TLSI 244.3M
- GHG 205.1M
- IPO Year
- TLSI N/A
- GHG 2018
- Fundamental
- Price
- TLSI $6.21
- GHG $1.83
- Analyst Decision
- TLSI Strong Buy
- GHG
- Analyst Count
- TLSI 3
- GHG 0
- Target Price
- TLSI $10.67
- GHG N/A
- AVG Volume (30 Days)
- TLSI 114.0K
- GHG 10.9K
- Earning Date
- TLSI 11-13-2025
- GHG 12-05-2025
- Dividend Yield
- TLSI N/A
- GHG 5.53%
- EPS Growth
- TLSI N/A
- GHG N/A
- EPS
- TLSI N/A
- GHG 0.26
- Revenue
- TLSI $40,207,000.00
- GHG $174,012,060.00
- Revenue This Year
- TLSI $57.25
- GHG $19.02
- Revenue Next Year
- TLSI $54.05
- GHG $8.26
- P/E Ratio
- TLSI N/A
- GHG $6.82
- Revenue Growth
- TLSI 49.52
- GHG N/A
- 52 Week Low
- TLSI $3.42
- GHG $1.76
- 52 Week High
- TLSI $6.36
- GHG $3.25
- Technical
- Relative Strength Index (RSI)
- TLSI 77.66
- GHG 37.05
- Support Level
- TLSI $3.79
- GHG $1.76
- Resistance Level
- TLSI $4.88
- GHG $1.99
- Average True Range (ATR)
- TLSI 0.47
- GHG 0.06
- MACD
- TLSI 0.17
- GHG -0.01
- Stochastic Oscillator
- TLSI 96.84
- GHG 26.16
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.